Predicting early bactericidal activity using pre-clinical data for tuberculosis drugs: a platform for model-informed drug discovery and development

Tweetable abstract

Combining PK-PD data from animal models and the hollow-fibre system model in conjunction with human PK data in a platform has the ability to accelerate pre-clinical drug development and predict the dosages likely to be successful in human clinical trialshttps://bit.ly/3K7IPcI